Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Medical Research Council Manual Muscle Test Score, Eversion	NCIT_C139235	[The numerical value that represents the result of a clinical assessment of muscle strength and function during eversion that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2).]
Failure To Meet Continuation Criteria	NCIT_C139236	[An indication that the subject has not been able to meet protocol-defined continuation criteria and will not continue to participate in the clinical trial.]
Randomized By Mistake	NCIT_C139237	[An indication that the subject was randomized but should not have been.]
Medical Research Council Manual Muscle Test Score, Flexion	NCIT_C139230	[The numerical value that represents the result of a clinical assessment of muscle strength and function during flexion that is based on the Medical Research Council Manual Muscle. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2).]
Medical Research Council Manual Muscle Test Score, Abduction	NCIT_C139231	[The numerical value that represents the result of a clinical assessment of muscle strength and function during abduction that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2).]
Medical Research Council Manual Muscle Test Score, Lateral Rotation	NCIT_C139232	[The numerical value that represents the result of a clinical assessment of muscle strength and function during lateral rotation that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2).]
Medical Research Council Manual Muscle Test Score, Dorsiflexion	NCIT_C139233	[The numerical value that represents the result of a clinical assessment of muscle strength and function during dorsiflexion that is based on the Medical Research Council Manual Muscle Test. (Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45, superseding War Memorandum No. 7. London: Her Majesty's Stationary Office; 1976. doi:10.1016/0022-510X(77)90205-2).]
Behcet Syndrome	NCIT_C34416	[A rare chronic inflammatory disorder of unknown etiology. It is characterized by the development of ulcers in the mouth and genital region and uveitis. Other signs and symptoms include arthritis, deep vein thrombosis and superficial thrombophlebitis.]
Benign Neoplasm of Lower Jaw Bone	NCIT_C34417	[A non-metastasizing neoplasm that arises from the lower jaw bone.]
Benign Bone Neoplasm	NCIT_C4880	[A neoplasm that arises from the bone or articular cartilage and does not invade adjacent tissues or metastasize to other anatomic sites.]
Vitamin B1 Deficiency	NCIT_C34418	[Abnormally low concentrations of vitamin B1 in the blood.]
Berry Aneurysm	NCIT_C34419	[A small cerebral artery aneurysm, characterized by a saccular appearance, that typically forms at the junction of vessels in the circle of Willis.]
Brain Aneurysm	NCIT_C27208
Bartter Syndrome	NCIT_C34412	[A rare inherited syndrome characterized by juxtaglomerular cell hyperplasia, hyperaldosteronism, hypokalemia, and alkalosis. Patients have high levels of plasma renin concentration which is not associated with hypertension.]
Basilar Artery Syndrome	NCIT_C34413	[A syndrome which occurs as a result of the occlusion of the basilar artery. It may be caused by atherosclerosis, embolism or hemorrhage. Clinical signs include dizziness, headache, vomiting, hemiparesis or hemiplegia, dysarthria, dysphagia, blurred vision and loss of consciousness. The clinical course is variable and is dependent upon the extent of the occlusion and the location of the clot along the basilar artery which determines the resultant neurologic impairment. Prognosis is dismal in cases where a complete occlusion occurs with rapid deterioration of neurological function.]
Basophilia	NCIT_C34414	[Abnormally high level of basophils in the blood.]
Beckwith-Wiedemann Syndrome	NCIT_C34415	[A genetic syndrome caused by abnormalities in chromosome 11. It is characterized by large birth weight, macroglossia, umbilical hernia, ear abnormalities, and hypoglycemia. Patients with this syndrome have an increased risk of developing embryonal tumors (gonadoblastoma, hepatoblastoma, Wilms tumor, Rhabdomyosarcoma) and adrenal cortex carcinomas.]
Protein Kinase C-Binding Protein 1	NCIT_C105610	[Protein kinase C-binding protein 1 (1186 aa, ~132 kDa) is encoded by the human ZMYND8 gene. This protein plays a role in protein kinase C function and may be a transcriptional regulator.]
Copper Cu 62 Ethylglyoxal Bis(thiosemicarbazone)	NCIT_C105611	[A radiopharmaceutical composed of the nonspecific perfusion agent ethylglyoxal bis(thiosemicarbazone) (ETS) linked to the beta-emitting, radioisotope copper Cu 62, with potential tumor imaging activity upon positron emitting tomography (PET). Upon injection, copper Cu 62-ETS distributes to various organs, especially the kidneys and the myocardium. Upon PET imaging, tumor blood flow can be visualized and the efficacy of antineoplastic and anti-angiogenic chemotherapeutics can be assessed. Cu62-ETS has a short half life of 9.74 minutes. ETS has an enhanced hyperemic response compared to other perfusion agents.]
Depatuxizumab Mafodotin	NCIT_C105612	[An epidermal growth factor receptor (EGFR) inhibitor, with potential antineoplastic activity. Upon intravenous infusion, depatuxizumab mafodotin inhibits the activity of EGFR, thereby preventing EGFR-mediated signaling. This may inhibit tumor growth in EGFR-overexpressing tumor cells. EGFR, a receptor tyrosine kinase overexpressed in certain tumor cell types, plays a key role in tumor cell proliferation and tumor vascularization.]